Request Demo
Last update 23 Jan 2025
Beijing Sannuo Jiayi Biotechnology Co. Ltd.
Subsidiary Company|
2002|
Beijing Shi, China
Last update 23 Jan 2025
Overview
Tags
Neoplasms
Infectious Diseases
Monoclonal antibody
Bispecific antibody
CAR-T
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20230449
多中心、开放性、剂量递增评价STSG-0002注射液对慢性乙型肝炎经治患者的安全性和有效性Ib/II期临床试验（长期随访）
[Translation] A multicenter, open-label, dose-escalation Phase Ib/II clinical trial to evaluate the safety and efficacy of STSG-0002 injection in patients with chronic hepatitis B who have been treated (long-term follow-up)
CTR20230448
多中心、开放性、剂量递增评价STSG-0002注射液对慢性乙型肝炎经治患者的安全性和有效性Ib/II期临床试验
[Translation] A multicenter, open-label, dose-escalation phase Ib/II clinical trial to evaluate the safety and efficacy of STSG-0002 injection in patients with chronic hepatitis B who have undergone treatment
CTR20201578
多中心、开放性、剂量递增评价STSG-0002注射液对无症状慢性HBV感染者的安全性、耐受性及初步有效性Ia期临床试验长期随访方案
[Translation] Long-term follow-up plan for a multicenter, open-label, dose-escalation phase Ia clinical trial to evaluate the safety, tolerability and preliminary efficacy of STSG-0002 injection in patients with asymptomatic chronic HBV infection
100 Clinical Results associated with Beijing Sannuo Jiayi Biotechnology Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Beijing Sannuo Jiayi Biotechnology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Sannuo Jiayi Biotechnology Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 04 Feb 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
3
Preclinical
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free